Versuchen GOLD - Frei
Amara bets on US expansion
Mint Chennai
|January 05, 2026
India’s second largest auto battery maker is doubling down on building local distribution network in North American market
Harshavardhana Gourineni, executive director at Amara Raja, said the imposition of tariffs has introduced a layer of uncertainty.
The country’s second-largest battery manufacturer, Amara Raja Energy and Mobility Ltd, is betting on expansion in the US market as part of its bid to double the share of revenue from exports in the next five years.
The Hyderabad-based auto ancillary firm is doubling down on building a local distribution network in the North American market to benefit from its edge in one of the advanced technologies in the lead acid battery industry to win incremental business at a time when tariffs in the US have brought uncertainty for Indian businesses, according to a top executive.
“One of the most exciting opportunities, especially on the lead acid side, is building ourselves up in North America. That’s where we see certain technology trends like a move towards AGM (Absorbent Glass Mat) batteries,” Harshavardhana Gourineni, executive director at Amara Raja, told Mint.
Diese Geschichte stammt aus der January 05, 2026-Ausgabe von Mint Chennai.
Abonnieren Sie Magzter GOLD, um auf Tausende kuratierter Premium-Geschichten und über 9.000 Zeitschriften und Zeitungen zuzugreifen.
Sie sind bereits Abonnent? Anmelden
WEITERE GESCHICHTEN VON Mint Chennai
Mint Chennai
Lenskart wants artificial intelligence to test your eyes
It expects AI-enabled eye testing to become the default foundational layer of eyecare delivery
3 mins
January 13, 2026
Mint Chennai
More companies to take a hit as labour codes debut
Reworked gratuity and leave encashments spell additional expenses for India Inc
2 mins
January 13, 2026
Mint Chennai
HC lifts ban on Zydus cancer biosimilar till patent expiry
In a relief for Zydus Lifesciences, a division bench of the Delhi High Court on Monday allowed the drugmaker to sell and market its biosimilar of the anticancer drug nivolumab in India, citing public interest.
2 mins
January 13, 2026
Mint Chennai
Trump’s investigation of Powell is also a warning to the next Fed chair
The criminal investigation into Federal Reserve Chair Jerome Powell isn’t ultimately about the Fed’s headquarters, or Powell, or even interest rates.
3 mins
January 13, 2026
Mint Chennai
States flag Almont-Kid syrup as tests find contaminants
Syrup found ‘Not of Standard Quality’ with contaminants like toxic ethylene glycol
1 mins
January 13, 2026
Mint Chennai
India at 100: Our choices today will define the next two decades
India's 2047 ambition is not guaranteed but achievable if we address all the potential pitfalls along our development path
4 mins
January 13, 2026
Mint Chennai
Now, inheritance works without probate—but why it still matters
Heirs can now act on a valid will without court cases, easing delays and unlocking assets in undisputed cases
6 mins
January 13, 2026
Mint Chennai
Why VCs have a new deep-tech playbook
where fundraising starts to drag,\" said Chand.
1 min
January 13, 2026
Mint Chennai
TCS, HCLTech deliver Q3 revenue surprise
clearer.
2 mins
January 13, 2026
Mint Chennai
US productivity is rising and it risks warping monetary policy
America's neutral rate ought to be going up but will the Fed listen?
3 mins
January 13, 2026
Listen
Translate
Change font size
